These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8491578)

  • 1. Role of lipids in the progression of renal disease in chronic renal failure: evidence from animal studies and pathogenesis.
    Shohat J; Boner G
    Isr J Med Sci; 1993 Apr; 29(4):228-39. PubMed ID: 8491578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipids and the progression of renal disease.
    Keane WF; O'Donnell MP; Kasiske BL; Schmitz PG
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S69-74. PubMed ID: 16989069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids in progression of renal disease.
    Oda H; Keane WF
    Kidney Int Suppl; 1997 Nov; 62():S36-8. PubMed ID: 9350676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of dietary lipids and renal eicosanoids on the progression of renal disease.
    Klahr S; Harris K
    Kidney Int Suppl; 1989 Nov; 27():S27-31. PubMed ID: 2699998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipids in patients with chronic renal failure on long-term, protein-restricted diets.
    Maschio G; Oldrizzi L; Rugiu C; Loschiavo C
    Am J Med; 1989 Nov; 87(5N):51N-54N. PubMed ID: 2486548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of lipid abnormalities in the pathogenesis of chronic, progressive renal disease.
    Kasiske BL; O'Donnell MP; Schmitz PG; Keane WF
    Adv Nephrol Necker Hosp; 1991; 20():109-25. PubMed ID: 2063707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipids and renal disease.
    Trevisan R; Dodesini AR; Lepore G
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S145-7. PubMed ID: 16565240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of renal failure: role of apolipoprotein B-containing lipoproteins.
    Attman PO; Samuelsson O; Alaupovic P
    Kidney Int Suppl; 1997 Dec; 63():S98-101. PubMed ID: 9407433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dietary polyunsaturated fatty acid supplementation in early renal insufficiency in dogs.
    Brown SA; Brown CA; Crowell WA; Barsanti JA; Kang CW; Allen T; Cowell C; Finco DR
    J Lab Clin Med; 2000 Mar; 135(3):275-86. PubMed ID: 10711867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dietary manipulation on the lipid abnormalities in patients with chronic renal failure.
    Maschio G; Oldrizzi L; Rugiu C; De Biase V; Loschiavo C
    Kidney Int Suppl; 1991 Apr; 31():S70-2. PubMed ID: 2046274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids and progressive renal failure.
    Keane WF
    Wien Klin Wochenschr; 1996; 108(14):420-4. PubMed ID: 8784983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of n-3 fatty acids on lipids and lipoproteins in patients treated with chronic haemodialysis: a randomized placebo-controlled intervention study.
    Svensson M; Schmidt EB; Jørgensen KA; Christensen JH
    Nephrol Dial Transplant; 2008 Sep; 23(9):2918-24. PubMed ID: 18436564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic differences in susceptibility to glomerular sclerosis: a role for lipids?
    Grond J; Muller EW; Weening JJ
    Am J Med; 1989 Nov; 87(5N):30N-33N. PubMed ID: 2486543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: effects of fish oil and vitamin E administration.
    Panzetta O; Cominacini L; Garbin U; Fratta Pasini A; Gammaro L; Bianco F; Davoli A; Campagnola M; De Santis A; Pastorino AM
    Clin Nephrol; 1995 Nov; 44(5):303-9. PubMed ID: 8605710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Special characteristics of atherosclerosis in chronic renal failure.
    Amann K; Tyralla K; Gross ML; Eifert T; Adamczak M; Ritz E
    Clin Nephrol; 2003 Jul; 60 Suppl 1():S13-21. PubMed ID: 12940530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of lipids in the progression of renal disease in systemic lupus erythematosus patients.
    Luzar B; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):716-21. PubMed ID: 11020963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperlipidemia and renal disease: the use of animal models in understanding pathophysiology and approaches to treatment.
    Stevenson FT; Kaysen GA
    Wien Klin Wochenschr; 1999 Apr; 111(8):307-14. PubMed ID: 10378311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.